Analysis of the toxicity induced by carboplatin and paclitaxel regimen in ovarian cancer patients
Objective: to analyze of the toxicities induced by carboplatin and paclitaxel regimen in ovarian cancer patients, seeking to identify possible risk factors related to its occurrence and clinical interventions. Method: a retrospective cohort study was conducted involving ovarian cancer patients, enro...
Main Authors: | Thaís A. GOUVÊA, Gabriela V. CHAVES, Mario J. SOBREIRA-DA-SILVA |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
2022-09-01
|
Series: | Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde |
Online Access: | https://rbfhss.org.br/sbrafh/article/view/823 |
Similar Items
-
Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer
by: Xiangbin Tan, et al.
Published: (2023-09-01) -
Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients
by: Zhenhua Du, et al.
Published: (2015-07-01) -
Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin
by: Shinichi Tate, et al.
Published: (2021-02-01) -
Effects of paclitaxel combined with carboplatin on expression of VEGF and tumor markers in ovarian cancer
by: TAN Shufen, YANG Xielan, YANG Linlin, LI Shuqing
Published: (2023-12-01) -
Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients
by: Femke M. de Man, et al.
Published: (2019-06-01)